Literature DB >> 17898074

Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1.

Heather Y Winter1, Tajhal Dayaram, Susan J Marriott.   

Abstract

Serum response factor (SRF) was recently shown to bind and activate the human T-cell leukemia virus type 1 (HTLV-1) promoter at bases -116 to -125 relative to the transcription start site. In addition to the SRF binding site (CArG box), serum response elements (SRE) also typically contain a binding site for a member of the ternary complex factor (TCF) family. Here we demonstrate the presence of two TCF binding sites upstream of the viral CArG box. Binding of the TCF family member Elk-1 to these sites was shown to activate transcription of the promoter. Based on these results, the position of the previously described viral SRE (vSRE) within the HTLV-1 promoter can be extended from -116 to -157 to include the two newly identified TCF sites. Purified Elk-1 bound to a probe containing the vSRE, and this complex formed a ternary complex with SRF. In addition, the complex formed by nuclear extract on this probe contained Elk-1, as shown by electrophoretic mobility shift assay supershift. Both of the predicted TCF sites independently bound Elk-1. Elk-1 activated transcription of the HTLV-1 long terminal repeat (LTR), and mutations within either of the TCF sites or the CArG box reduced responsiveness of the LTR to Elk-1. Chromatin immunoprecipitation demonstrated that Elk-1 associates with the HTLV-1 LTR in vivo. These results identify a functional SRE within the HTLV-1 LTR and suggest that both Elk-1 and SRF play important roles in regulating basal HTLV-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898074      PMCID: PMC2169132          DOI: 10.1128/JVI.00968-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Coexamination of site-specific transcription factor binding and promoter activity in living cells.

Authors:  K E Boyd; P J Farnham
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.

Authors:  M Shuh; S A Hill; D Derse
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

3.  Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression.

Authors:  Hsin-Ching Lin; Michele Hickey; Lydia Hsu; Daniel Medina; Arnold B Rabson
Journal:  Virology       Date:  2005-08-15       Impact factor: 3.616

4.  Determinants of DNA-binding specificity of ETS-domain transcription factors.

Authors:  P Shore; A J Whitmarsh; R Bhaskaran; R J Davis; J P Waltho; A D Sharrocks
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 tax transactivation of the serum response element.

Authors:  M Shuh; D Derse
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway.

Authors:  Celine Charvet; Patrick Auberger; Sophie Tartare-Deckert; Alain Bernard; Marcel Deckert
Journal:  J Biol Chem       Date:  2002-02-21       Impact factor: 5.157

7.  Differential usage of signal transduction pathways defines two types of serum response factor target gene.

Authors:  D Gineitis; R Treisman
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

8.  Identification of an initiator-like element within the HTLV-I promoter.

Authors:  D R Wycuff; M D Goff; S J Marriott
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

9.  Transcriptional silencing in yeast is associated with reduced nucleosome acetylation.

Authors:  M Braunstein; A B Rose; S G Holmes; C D Allis; J R Broach
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

10.  c-Myc target gene specificity is determined by a post-DNAbinding mechanism.

Authors:  K E Boyd; J Wells; J Gutman; S M Bartley; P J Farnham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  5 in total

1.  Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression.

Authors:  Dustin C Edwards; Susan J Marriott
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

2.  Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.

Authors:  Sylvain Fauquenoy; Gwenaëlle Robette; Anna Kula; Caroline Vanhulle; Sophie Bouchat; Nadège Delacourt; Anthony Rodari; Céline Marban; Christian Schwartz; Arsène Burny; Olivier Rohr; Benoit Van Driessche; Carine Van Lint
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

3.  HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models.

Authors:  Victoria Maksimova; Susan Smith; Jaideep Seth; Cameron Phelps; Stefan Niewiesk; Yorifumi Satou; Patrick L Green; Amanda R Panfil
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

4.  HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.

Authors:  Robert Currer; Rachel Van Duyne; Elizabeth Jaworski; Irene Guendel; Gavin Sampey; Ravi Das; Aarthi Narayanan; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2012-11-30       Impact factor: 5.640

Review 5.  Regulation of Expression and Latency in BLV and HTLV.

Authors:  Aneta Pluta; Juan P Jaworski; Renée N Douville
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.